Kagan Ozer1, Sunitha Malay, Serdar Toker, Kevin C Chung. 1. Ann Arbor, Mich.; and Meram, Turkey From the Department of Orthopaedic Surgery and the Section of Plastic Surgery, Department of Surgery, University of Michigan Health System; and the Department of Orthopaedic Surgery, Konya University.
Abstract
BACKGROUND: Establishing the minimal clinically important difference for patient-reported outcomes questionnaires is essential in outcomes research to evaluate the patient's perspective of treatment effectiveness. The authors aim to determine the minimal clinically important difference after carpal tunnel release in diabetic and nondiabetic patients using the Boston Carpal Tunnel Questionnaire. METHODS: The authors prospectively evaluated 114 patients (87 nondiabetic and 27 diabetic patients) undergoing carpal tunnel release. In addition to standard history and physical examination, the authors obtained preoperative electrodiagnostic studies to confirm carpal tunnel syndrome. The Boston Carpal Tunnel Questionnaire was administered before and after surgery at 3 and 6 months. Patients were asked about their level of satisfaction at the final follow-up visit. The authors applied the receiver operating characteristic curve approach to determine the minimal clinically important difference of symptom and function severity scales of the questionnaire. The authors used patient satisfaction as the reference standard to compare against the standardized change in scores after surgery for the two groups. RESULTS: For both diabetic and nondiabetic patients, symptom and function severity scales showed large effect sizes of greater than 0.8 at 3 and 6 months after surgery. At 6 months after surgery, to be satisfied, diabetic patients required a minimal clinically important difference of 1.55 and 2.05 for symptom and function scales, respectively, whereas nondiabetic patients required 1.45 and 1.6, respectively. CONCLUSIONS: Diabetic patients needed a greater improvement in Boston Carpal Tunnel Questionnaire score to be satisfied on functional and symptom severity scales than nondiabetic patients. Overall, diabetic patients had less improvement in Boston Carpal Tunnel Questionnaire final scores compared with nondiabetics. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.
BACKGROUND: Establishing the minimal clinically important difference for patient-reported outcomes questionnaires is essential in outcomes research to evaluate the patient's perspective of treatment effectiveness. The authors aim to determine the minimal clinically important difference after carpal tunnel release in diabetic and nondiabeticpatients using the Boston Carpal Tunnel Questionnaire. METHODS: The authors prospectively evaluated 114 patients (87 nondiabetic and 27 diabeticpatients) undergoing carpal tunnel release. In addition to standard history and physical examination, the authors obtained preoperative electrodiagnostic studies to confirm carpal tunnel syndrome. The Boston Carpal Tunnel Questionnaire was administered before and after surgery at 3 and 6 months. Patients were asked about their level of satisfaction at the final follow-up visit. The authors applied the receiver operating characteristic curve approach to determine the minimal clinically important difference of symptom and function severity scales of the questionnaire. The authors used patient satisfaction as the reference standard to compare against the standardized change in scores after surgery for the two groups. RESULTS: For both diabetic and nondiabeticpatients, symptom and function severity scales showed large effect sizes of greater than 0.8 at 3 and 6 months after surgery. At 6 months after surgery, to be satisfied, diabeticpatients required a minimal clinically important difference of 1.55 and 2.05 for symptom and function scales, respectively, whereas nondiabeticpatients required 1.45 and 1.6, respectively. CONCLUSIONS:Diabeticpatients needed a greater improvement in Boston Carpal Tunnel Questionnaire score to be satisfied on functional and symptom severity scales than nondiabeticpatients. Overall, diabeticpatients had less improvement in Boston Carpal Tunnel Questionnaire final scores compared with nondiabetics. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.
Authors: Floriaan G C M De Kleermaeker; Jan Meulstee; Franka Claes; Kristel M Kasius; Wim I M Verhagen Journal: J Neurol Date: 2017-10-09 Impact factor: 4.849
Authors: Verena J M M Schrier; Stefanie Evers; Jennifer R Geske; Walter K Kremers; Hector R Villarraga; Sanjeev Kakar; Ruud W Selles; Steven E R Hovius; Russell Gelfman; Peter C Amadio Journal: Ultrasound Med Biol Date: 2019-09-02 Impact factor: 2.998
Authors: Nikolas H Kazmers; Man Hung; Jerry Bounsanga; Maren W Voss; Abby Howenstein; Andrew R Tyser Journal: J Hand Surg Am Date: 2019-05-06 Impact factor: 2.230
Authors: Andrew R Stephens; Andrew R Tyser; Angela P Presson; Brian Orleans; Angela A Wang; Douglas T Hutchinson; Nikolas H Kazmers Journal: J Hand Surg Glob Online Date: 2020-12-04
Authors: Kyle R Eberlin; Christopher J Dy; Mark D Fischer; James L Gluck; F Thomas D Kaplan; Thomas J McDonald; Larry E Miller; Alexander Palmer; Marc E Walker; James F Watt Journal: Medicine (Baltimore) Date: 2022-10-14 Impact factor: 1.817